Clinical Trial Update: MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction

View source ↗

Summary

The clinical trial evaluating the MGuard Prime Embolic Protection Stent in patients with ST-elevation myocardial infarction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• MGuard Prime Embolic Protection Stent

Snippet

Sponsor: InspireMD | Conditions: ST Elevation Myocardial Infarction | Status: TERMINATED